Market Access & Reimbursement Strategy

Delivered a clear reimbursement roadmap, highlighting feasible coding options, evidence requirements, and potential funding pathways. The insights informed the client’s national strategy and shaped early discussions with local stakeholders, ensuring regulatory and financial readiness for launch.

The client sought to assess reimbursement pathways and procedural coding opportunities for a new neurostimulation therapy in Poland. The key challenge was to identify optimal access routes under evolving regulations, ensure alignment with HTA and payer expectations, and benchmark against comparable devices already reimbursed in EU markets.

• Conducted a comprehensive analysis of Polish reimbursement frameworks (AOTMiT, NFZ, MoH) for implantable neuromodulation technologies.
• Mapped existing procedure codes and funding mechanisms under pilot programs and NFZ Art. 48e initiatives.
• Benchmarked competitor devices and their reimbursement trajectories across the EU.
• Developed strategic recommendations for market entry, positioning, and evidence generation.

8 weeks